register

News & Trends - Pharmaceuticals

NSW pharmacists awarded emergency dispensing special authority during COVID-19

Health Industry Hub | March 26, 2020 |

Pharma News: The New South Wales Government extended the special authority for emergency supply of medicines without a prescription, in a move that has been welcomed by the Pharmaceutical Society of Australia (PSA).

Patients will be able to receive a maximum PBS quantity or pack size until 30th September 2020 without a prescription, where the pharmacist is satisfied there is immediate need.

The medicine must have been previously prescribed and be for the continuation of current essential treatment where it is impractical to obtain a prescription.

PSA NSW President Professor Peter Carroll said “PSA fully supports and thanks the NSW Government for this very sensible approach which will reduce the concerns of those in the community who may find it hard to access medicines in this challenging environment,” he said.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

“This will enable patients to still have ongoing access to their regular medicines in the event that they are not able to see their doctor for a prescription or must self-isolate.

“We are hearing from patients that their GPs are overwhelmed and can be difficult to get an appointment. This flexible approach to healthcare will ensure pharmacists can continue to support the community during the COVID-19 Pandemic.”

“As the peak national body for pharmacists, PSA has called for and worked with the NSW Government to allow the continuation of emergency dispensing that was put in place during the recent bushfire crisis to ensure patients and members of the community continue to gain access to much needed medicines.”

Customer engagement during COVID-19. Health Industry Hub combines expertise in delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry. Contact us.


News & Trends - MedTech & Diagnostics

Pathology reforms: Frozen fees, windfall gains, and the fight for bulk-billing

Pathology reforms: Frozen fees, windfall gains, and the fight for bulk-billing

Health Industry Hub | May 7, 2024 |

Diagnostics & MedTech News: For nearly a quarter-century, pathology fees have remained stagnant – a situation deemed patently unfair by […]

More


News & Trends - Biotechnology

Superiority of cell-based influenza vaccine revealed in RWE Study

Superiority of cell-based flu vaccine revealed in RWE Study

Health Industry Hub | May 7, 2024 |

Biotech News: Vaccines stand as the primary strategy to mitigate the considerable morbidity, mortality, and economic burden associated with influenza. […]

More


News & Trends - Pharmaceuticals

Amgen and Arrotex expand partnership to boost distribution and patient support in osteoporosis

Amgen and Arrotex expand partnership to boost distribution and patient support in osteoporosis

Health Industry Hub | May 7, 2024 |

Pharma News: Pharmaceutical company, Amgen Australia, and Arrotex Pharmaceuticals, the largest provider of generics and private label over-the-counter (OTC) medications, […]

More


News & Trends - Pharmaceuticals

Heart week: Uniting patient and cardiologist voices to shape patient outcomes

Heart Week: Uniting patient and cardiologist voices in shaping a new future for patient outcomes

Health Industry Hub | May 6, 2024 |

Coinciding with the start of the Heart Week (9 – 12 May), Professor Gemma Figtree, Interventional Cardiologist and Immediate Past […]

More


This content is copyright protected. Please subscribe to gain access.